FINVX | TRIGX | FINVX / TRIGX | |
Total Expense Ratio | 0.01 | 0.87 | 1% |
Annual Report Gross Expense Ratio | 0.01 | 0.87 | 1% |
Fund Existence | 15 years | 26 years | - |
Gain YTD | 14.430 | 13.361 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.4B | 13.3B | 116% |
Annual Yield % from dividends | 4.09 | 2.28 | 180% |
Returns for 1 year | 12.88 | 15.34 | 84% |
Returns for 3 years | 36.78 | 36.99 | 99% |
Returns for 5 years | 142.78 | 118.60 | 120% |
Returns for 10 years | 69.53 | 58.76 | 118% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 19.65 | 0.70 | +3.69% |
ProShares UltraShort Nasdaq Biotech | |||
OCTW | 34.51 | -0.80 | -2.27% |
AllianzIM US Large Cap Buffer20 Oct ETF | |||
XPH | 40.69 | -1.51 | -3.58% |
SPDR® S&P Pharmaceuticals ETF | |||
ESML | 36.53 | -2.70 | -6.88% |
iShares ESG Aware MSCI USA Small-Cap ETF | |||
TRFM | 32.71 | -2.53 | -7.19% |
AAM Transformers ETF |